Insiders · Profile

Sapir Alex

See Remarks at Fulcrum Therapeutics. Filing since 4 Mar 2024. CIK 0001709415

Company

Date

Role

Action

Shares

Amount

Of holding

FULC Fulcrum Therapeutics, Inc.

4 Mar 2024

See Remarks

Bought

43,360

$492.03K

opened

1 decision on file.